Cancer-associated fibroblasts (CAFs), a kind of highly heterogeneous and hyper‐activated fibroblasts, have been demonstrated to promote tumor initiation, migration, inflammation, and drug resistance via the secretion of chemokines and cytokines, such as VEGFA and CXCL12 (36–38). The gene discussed is CXCL12; the disease is neoplasm.